Literature DB >> 4351533

[Herpes simplex virus, type II: microbiology and clinical experiences with attenuated vaccine].

T Nasemann, G Schaeg.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4351533

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  5 in total

Review 1.  Herpes simplex viruses: is a vaccine tenable?

Authors:  Richard J Whitley; Bernard Roizman
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Herpes genitalis in guinea-pigs. I. Kinetic study in infection with Herpesvirus hominis type 2.

Authors:  B Lukás; W Wiesendanger; K H Schmidt-Ruppin
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

3.  The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

Authors:  G R Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

Review 4.  Herpes simplex virus type 2 vaccines: new ground for optimism?

Authors:  L Aurelian
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

5.  [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].

Authors:  R Jarisch; I Sandor
Journal:  Arch Dermatol Res       Date:  1977-04-27       Impact factor: 3.017
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.